Tandem Diabetes Care Share Price (NASDAQ: TNDM)

$10.82

▲

0.16

(1.5%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Tandem Diabetes Care Stock chart to analyse performance

Tandem Diabetes Care stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$10.77
Today's High:$11.15
$10.82
0.46%
Downside
Day's Volatility :3.41%
Upside
2.96%
52 Weeks Low:$9.98
52 Weeks High:$47.60
$10.82
7.76%
Downside
52 Weeks Volatility :79.03%
Upside
77.27%

Tandem Diabetes Care Stock Returns

Period	Tandem Diabetes Care, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-52.4%	2.3%	0.0%
6 Months	-66.83%	-5.9%	0.0%
1 Year	-76.33%	-10.9%	0.0%
3 Years	-79.01%	2.3%	-11.0%

Tandem Diabetes Care, Inc. Key Stats

Check Tandem Diabetes Care key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$10.66
Open	$11.03
Today's High	$11.15
Today's Low	$10.77
Market Capitalization	$720.3M
Today's Volume	$2.1M
52 Week High	$47.6
52 Week Low	$9.98
Revenue TTM	$1.0B
EBITDA	$-75.9M
Earnings Per Share (EPS)	$-3.08
Profit Margin	-20.51%
Quarterly Earnings Growth YOY	-0.37%
Return On Equity TTM	-111.92%

Stock Returns calculator for Tandem Diabetes Care Stock including INR - Dollar returns

The Tandem Diabetes Care stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tandem Diabetes Care investment value today

Current value as on today

₹27,881

Returns

₹72,119

(-72.12%)

Returns from Tandem Diabetes Care Stock

₹76,329 (-76.33%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Tandem Diabetes Care Stock

100%

Period: Jul 17, 2025 to Aug 16, 2025. Change in 30 Days versus previous period

Search interest for Tandem Diabetes Care Stock from India on INDmoney has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Tandem Diabetes Care, Inc.

Name
Holdings %
Name
Holdings %
BlackRock Inc
16.33%
Vanguard Group Inc
10.80%
Sessa Capital IM LP
6.61%
GW&K Investment Management, LLC
4.24%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
4.02%
State Street Corp
3.98%

Analyst Recommendation on Tandem Diabetes Care Stock

Rating

Trend

Buy

65%Buy

30%Hold

4%Sell

Based on 23 Wall street analysts offering stock ratings for Tandem Diabetes Care(by analysts ranked 0 to 5 stars)

Tandem Diabetes Care Share Price Target

What analysts predicted

Upside of 109.96%

Target:

$22.72

Current:

$10.82

Tandem Diabetes Care share price target is $22.72, a slight Upside of 109.96% compared to current price of $10.82 as per analysts' prediction.

Tandem Diabetes Care Stock Insights

Price Movement
In the last 1 month, TNDM stock has moved down by -29.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 234.42M → 240.67M (in $), with an average increase of 2.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -130.55M → -52.4M (in $), with an average increase of 149.2% per quarter
TNDM vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 31.9% return, outperforming this stock by 107.7%
TNDM vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 143.2% return, outperforming this stock by 222.7%
Price to Sales
ForTNDM every $1 of sales, investors are willing to pay $0.7, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Tandem Diabetes Care, Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$362.3M	↑ 97.05%
Net Income	$-24.8M	↓ 79.81%
Net Profit Margin	-6.83%	↑ 59.85%

	FY20	Y/Y Change
Revenue	$498.8M	↑ 37.68%
Net Income	$-34.4M	↑ 38.9%
Net Profit Margin	-6.89%	↓ 0.06%

	FY21	Y/Y Change
Revenue	$702.8M	↑ 40.89%
Net Income	$15.6M	↓ 145.27%
Net Profit Margin	2.21%	↑ 9.1%

	FY22	Y/Y Change
Revenue	$801.2M	↑ 14.0%
Net Income	$-94.6M	↓ 707.7%
Net Profit Margin	-11.81%	↓ 14.02%

	FY23	Y/Y Change
Revenue	$747.7M	↓ 6.68%
Net Income	$-222.6M	↑ 135.33%
Net Profit Margin	-29.77%	↓ 17.96%

	FY24	Y/Y Change
Revenue	$940.2M	↑ 25.74%
Net Income	$-96.0M	↓ 56.86%
Net Profit Margin	-10.21%	↑ 19.56%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$191.7M	↓ 2.6%
Net Income	$-42.7M	↑ 42.37%
Net Profit Margin	-22.29%	↓ 7.04%

	Q2 FY24	Q/Q Change
Revenue	$221.9M	↑ 15.77%
Net Income	$-30.8M	↓ 27.86%
Net Profit Margin	-13.89%	↑ 8.4%

	Q3 FY24	Q/Q Change
Revenue	$363.3M	↑ 63.71%
Net Income	$-23.3M	↓ 24.54%
Net Profit Margin	-6.4%	↑ 7.49%

	Q4 FY24	Q/Q Change
Revenue	$282.6M	↓ 22.2%
Net Income	$755.0K	↓ 103.25%
Net Profit Margin	0.27%	↑ 6.67%

	Q1 FY25	Q/Q Change
Revenue	$234.4M	↓ 17.06%
Net Income	$-130.6M	↓ 17392.19%
Net Profit Margin	-55.69%	↓ 55.96%

	Q2 FY25	Q/Q Change
Revenue	$240.7M	↑ 2.67%
Net Income	$-52.4M	↓ 59.86%
Net Profit Margin	-21.77%	↑ 33.92%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$194.2M	↑ 116.22%

	FY20	Y/Y Change
Profit	$260.5M	↑ 34.14%

	FY21	Y/Y Change
Profit	$376.2M	↑ 44.41%

	FY22	Y/Y Change
Profit	$413.0M	↑ 9.77%

	FY23	Y/Y Change
Profit	$367.7M	↓ 10.97%

	FY24	Y/Y Change
Profit	$489.6M	↑ 33.15%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$94.7M	↑ 1.48%

	Q2 FY24	Q/Q Change
Profit	$112.8M	↑ 19.14%

	Q3 FY24	Q/Q Change
Profit	$124.7M	↑ 10.51%

	Q4 FY24	Q/Q Change
Profit	$157.5M	↑ 26.31%

	Q1 FY25	Q/Q Change
Profit	$118.4M	↓ 24.8%

	Q2 FY25	Q/Q Change
Profit	$125.9M	↑ 6.29%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$41.9M	↓ 603.73%
Investing Cash Flow	$-57.0M	↓ 37.23%
Financing Cash Flow	$24.2M	↓ 79.34%

	FY20	Y/Y Change
Operating Cash Flow	$24.7M	↓ 41.13%
Investing Cash Flow	$-296.1M	↑ 419.81%
Financing Cash Flow	$314.4M	↑ 1198.95%

	FY21	Y/Y Change
Operating Cash Flow	$111.4M	↑ 351.41%
Investing Cash Flow	$-186.9M	↓ 36.88%
Financing Cash Flow	$51.9M	↓ 83.48%

	FY22	Y/Y Change
Operating Cash Flow	$50.5M	↓ 54.68%
Investing Cash Flow	$33.2M	↓ 117.75%
Financing Cash Flow	$16.9M	↓ 67.5%

	FY23	Y/Y Change
Operating Cash Flow	$-31.8M	↓ 163.04%
Investing Cash Flow	$-85.7M	↓ 358.5%
Financing Cash Flow	$4.1M	↓ 75.63%

	FY24	Y/Y Change
Operating Cash Flow	$24.2M	↓ 176.16%
Investing Cash Flow	$-23.5M	↓ 72.61%
Financing Cash Flow	$8.4M	↑ 103.43%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-8.0M	↑ 10.81%
Investing Cash Flow	$-5.1M	↓ 69.51%
Financing Cash Flow	$13.6M	↑ 419.14%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-5.3M	↓ 34.03%
Investing Cash Flow	$-3.5M	↓ 29.98%
Financing Cash Flow	$-3.0M	↓ 122.1%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$26.8M	↓ 607.66%
Investing Cash Flow	$-19.9M	↑ 462.03%
Financing Cash Flow	$-4.5M	↑ 50.53%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$10.7M	↓ 59.98%
Investing Cash Flow	$5.0M	↓ 125.18%
Financing Cash Flow	$2.3M	↓ 150.94%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-18.3M	↓ 270.55%
Investing Cash Flow	$9.2M	↑ 83.35%
Financing Cash Flow	$-4.7M	↓ 303.65%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-9.5M	↓ 48.05%
Investing Cash Flow	$58.1M	↑ 532.81%
Financing Cash Flow	$-39.7M	↑ 747.12%

Tandem Diabetes Care Technicals Summary

Sell

Neutral

Buy

Tandem Diabetes Care is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Tandem Diabetes Care, Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Tandem Diabetes Care, Inc.	-26.74%	-66.83%	-76.33%	-79.01%	-89.5%
Medtronic Plc	3.78%	8.05%	9.64%	-2.35%	-8.43%
Edwards Lifesciences Corp.	2.29%	3.4%	14.62%	-21.37%	-0.45%
Boston Scientific Corp.	-0.41%	-2.03%	31.18%	142.11%	162.42%
Stryker Corporation	-1.94%	-0.97%	11.96%	72.91%	101.66%
Abbott Laboratories	6.53%	1.21%	17.74%	19.82%	30.5%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Tandem Diabetes Care, Inc.	473.44	NA	0.0	-2.23	-1.12	-0.06	NA	1.97
Medtronic Plc	25.51	25.51	2.16	5.46	0.1	0.04	0.03	37.46
Edwards Lifesciences Corp.	32.74	32.74	4.67	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	61.99	61.99	1.81	2.98	0.12	0.05	NA	15.14
Stryker Corporation	50.27	50.27	2.15	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.22	16.22	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Tandem Diabetes Care, Inc.	Buy	$720.3M	-89.5%	473.44	-20.51%
Medtronic Plc	Buy	$118.0B	-8.43%	25.51	13.9%
Edwards Lifesciences Corp.	Buy	$45.9B	-0.45%	32.74	72.96%
Boston Scientific Corp.	Buy	$154.3B	162.42%	61.99	13.55%
Stryker Corporation	Buy	$144.7B	101.66%	50.27	12.25%
Abbott Laboratories	Buy	$225.0B	30.5%	16.22	32.43%

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Organization	Tandem Diabetes Care
Employees	2650
CEO	Mr. John F. Sheridan
Industry	Health Technology

Key Management of Tandem Diabetes Care, Inc.

Name	Title
Mr. John F. Sheridan	President, CEO & Director
Ms. Leigh A. Vosseller	Executive VP, CFO & Treasurer
Mr. Jean-Claude E. Kyrillos	Executive VP & COO
Ms. Susan M. Morrison	Executive VP & Chief Administrative Officer
Ms. Elizabeth Anne Gasser	Executive VP and Chief Strategy & Product Officer
Mr. Mark Novara	Executive VP & Chief Commercial Officer
Mr. Rick A. Carpenter	Chief Technical Officer
Ms. Shannon M. Hansen J.D.	Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary
Mr. Tom Fox	Chief Human Resources Officer
Dr. Jordan Pinsker M.D.	Chief Medical Officer

Important FAQs about investing in TNDM Stock from India :

What is Tandem Diabetes Care share price today?

Tandem Diabetes Care share price today is $10.82 as on August 16, 2025 at 1:29 AM IST at the close of the market. Tandem Diabetes Care share today touched a day high of $11.15 and a low of $10.77.

What is the 52 week high and 52 week low for Tandem Diabetes Care share?

Tandem Diabetes Care share touched a 52 week high of $47.60 and a 52 week low of $9.98. Tandem Diabetes Care stock price today, August 16, 2025 at 1:29 AM IST is trending at $10.82, lower by 77.27% versus the 52 week high.

How to invest in Tandem Diabetes Care Stock (TNDM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tandem Diabetes Care on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tandem Diabetes Care Shares that will get you 0.1386 shares as per Tandem Diabetes Care share price of $10.82 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Tandem Diabetes Care Stock (TNDM) from India?

Indian investors can start investing in Tandem Diabetes Care (TNDM) shares with as little as ₹87.492 or $1 (as of August 17, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Tandem Diabetes Care stock (as per the Rupee-Dollar exchange rate as on August 17, 2025). Based on Tandem Diabetes Care share’s latest price of $10.82 as on August 16, 2025 at 1:29 AM IST, you will get 0.9242 shares of Tandem Diabetes Care. Learn more about fractional shares .

What are the returns that Tandem Diabetes Care has given to Indian investors in the last 5 years?

Tandem Diabetes Care stock has given -89.5% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?